ASH Interviews on CML by PatientPower now available

patientpower-andrew-schorrThe following video interviews done by our partner Andrew Schorr of PatientPower have just been published and are available as webstreams:

  • A CML Advocate's Perspective on News from ASH 2012: Interview with Greg Stephens, National CML Society
  • The latest in CML: a Global Patient Advocate's Perspective with Jan Geissler, CML Advocates Network
  • An Expert’s Perspective on Changing CML Treatment Options: Dr. Moshe Talpaz discusses whether or not the "big guns"of treatment should be used up front or saved as a later option
  • Ponatinib Study Brings Positive Results For the Most Resistant Types of CML, Dr. Jorge Cortes

 See the video interviews here


Please donate!

Please donate!


Tweet Feed

From 26 April “Sprycel is indicated for the treatment of paediatric patients with: newly diagnosed Ph+ CML in chron……

Retweeted Saturday, 19 May 2018

Progress is impossible without change and those who cannot change their minds cannot change anything... 🤔…

Retweeted Sunday, 13 May 2018

Encuesta Parada de tratamiento #TFR4CML En #CMLHZ18 vimos primeros resultados sobre 600 respuestas ya recibidas a l……

Retweeted Wednesday, 09 May 2018